Clinical Trial

Potential Correlation Between Heart Rate Variability With Cardiovascular Risk at Different Stages of Metabolic Syndrome

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated March 12, 2024 (before its estimated September 1, 2024 completion). Its status may not reflect the trial's current state.
Summary
The study aims to assess the beat-to-beat Heart rate variability (HRV) in different stages of metabolic diseases, including pre-diabetic and diabetic patients, compared to non-diabetic individuals. Heart rate variability will be compared for some antidiabetic drugs used in different stages of metabolic diseases and correlated to different metabolic and inflammatory mediators.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2024-03-08.
Trial Details
NCT Number NCT06305195
Lead Sponsor Alexandria University
Conditions Diabetes Mellitus
Enrollment 155 participants
Start Date 2023-08-23
Primary Completion 2024-09-01 (estimated)
Study Completion 2026-10-21 (estimated)
Updated on ClinicalTrials.gov 2024-03-12